Archive for May, 2009

Grassley Likely to Stay on Finance Committee

May 4th, 2009. By Evelyn Pringle

May 4, 2009

Update

In great news to start off the week, Congressional Quarterly’s Kathleen Hunter is reporting that Senator Charles Grassley will likely hold onto his position on the US Senate Finance Committee until 2011.

“Grassley said last week that he preferred to remain as the top Republican on the Finance panel for the remainder of the 111th Congress but might reconsider if something was “going to happen in the interim” that would keep him from taking over the top Judiciary post in 2011,” she wrote.

“Alabama Sen. Jeff Sessions will take over the top Republican spot on the Judiciary Committee for the remainder of the 111th Congress and then yield to Charles E. Grassley of Iowa in 2011, under a deal reached between the two, a senior GOP aide confirmed Monday,” Hunter reports.

This news has to be a big let down for Big Pharma and all the hangers-on whose financial dealings with drug and device companies have come under the microscope through Grassley’s relentless investigations.

Tags: FDA
Posted in Emerging Issues | 3 Comments »

Say It Isn’t So – Grassley May Leave Finance Committee

May 1st, 2009. By Evelyn Pringle

In what could be the best news in years for certain FDA officials, Big Pharma and drug company funded front groups, The Hill is reporting that Senator Charles Grassley is considering leaving his high ranking post on the US Senate Finance Committee to become the ranking Republican on the Senate Judiciary Committee. Read the rest of this entry »

Tags: FDA
Posted in Emerging Issues | 2 Comments »